logo

Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash

By: odaily.com|2025/07/14 11:31:37

Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)

Bitget vs. Binance vs. WEEX биржа: Сравнительный анализ CEX и потенциал токенов 2025
Прогноз Цены yearn.finance(YFI) Coin: Рост на 15% к Апрелю 2025 – Достигнет ли $6000?

Вам также может понравиться

Поделиться
copy

Растущие активы

Последние новости криптовалют

10:50

Европейский альянс Stablecoin назначил бывшего исполнительного директора Coinbase главным исполнительным директором

10:27

Ethereum ICO Whale with 254,900 Tokens Nearing Liquidation, Deposited 23,000 ETH to CEX in the Past Week

10:24

The Central Bank of Russia has confirmed that it may relax cryptocurrency regulation rules.

10:22

OECD: ожидает, что Федеральная резервная система "постепенно" понизит ключевую процентную ставку до 3,25% - 3,5%

10:20

Asset Management Giant Tidal Investments Acquires Approximately $60 Million in Strategy Stock

Еще
Сообщество
icon
icon
icon
icon
icon
icon
icon
icon
icon
icon

Служба поддержки：@weikecs

Деловое сотрудничество：@weikecs

Количественная торговля и ММ：[email protected]

VIP-программа：[email protected]